Stocks · Health care · Biological Products, (No Diagnostic Substances)

Hemab Therapeutics Holdings, Inc.

COAG

United States Fiscal year ends December CIK 0002114044

31.62

+2.36%

Close, 9 Oct 2026 · USD

Alert on the numbers Alert on insider trades

Price, with every insider trade on it

Closing prices, 12 months · point at a dot for who traded, or at the line for the close

31.62 on 9 Oct 2026

11 buys0 sales at will0 planned sales

From Form 4, most recent first

Date	Insider	Type	Value	Of own stake
16 Jun 2026	RA CAPITAL MANAGEMENT, L.P. 10% owner	Bought	$1.54M	1.0%
15 Jun 2026	RA CAPITAL MANAGEMENT, L.P. 10% owner	Bought	$152.97K	0.1%
20 May 2026	RA CAPITAL MANAGEMENT, L.P. 10% owner	Bought	$24.84K	0.0%
19 May 2026	RA CAPITAL MANAGEMENT, L.P. 10% owner	Bought	$94.94K	0.1%
12 May 2026	RA CAPITAL MANAGEMENT, L.P. 10% owner	Bought	$159.04K	0.1%
11 May 2026	RA CAPITAL MANAGEMENT, L.P. 10% owner	Bought	$989.23K	0.6%